Versión de HTML Básico
114
Pedro Moreira
Propranolol in the treatment of an extensive facial and orbital
infantile hemangioma
2. Léauté-Labrèze C, Dumas de La Roque E, Hubiche T, et al. Propra-
nolol for Severe Hemangiomas of Infancy. N Engl J Med. 2008;358:2649-
51.
3. Lawley LP, Siegfried E, Todd JL. Propranolol Treatment for he-
mangioma of Infancy: Risks and Recommendations. Pediatr Dermatol.
2009;26:610-4.
4. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangio-
mas: current knowledge, future directions: proceedings of a research
workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Marland,
USA. Pediatr Dermatol 2005;22:383-406.
5. Starkey E, Shahidullah H. Propranolol for Infantile Haemangio-
mas: a review. Arch Dis Child. 2011;96:890-3.
6. Bertrand J, Sammour R, Meluaig C, et al. Propranolol in the
treatment of problematic infantile hemangioma: review of 35 con-
secutive patients from a vascular anomalies clinic. J Cutan Med Surg.
2012;16(2):115-21.
7. Zaher H, Rasheed H, Hegazy R, et al. Oral propranolol: an
effective, safe treatment for infantile hemangiomas. Eur J Dermatol.
2011;21(4)558-63.
8. Fay A, Nguyen J, Jakobiec F, et al. Propranolol for isolated orbital
infantile hemangiomas. Arch Ophthalmol. 2010;128(2):256-8.
9. Li Y, McCahon E, Rowe N, et al. Succesful treatment of infantile
haemangiomas of the orbit with propranolol. Clin Experiment Ophthal-
mol. 2010;38(6):554-9.
10. Manunza F, Syed S, Laguda B, et al. Propranolol for complica-
ted infantile hemangiomas: a case series of 30 infants. Br J Dermatol.
2010;162:466-8.